Home
About Us
In this Issue
Previous Issue
Editorial Board
How to Contribute
Advertise with Us
Editorial Calendar
Subcribe Now
Global Healthcare Releases provided by Business Wire

 The Publication & Databases on Biotechnology in the Asia Pacific
 
 More free   feature articles 
  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

EYE ON CHINA
Sagent Pharmaceuticals launches National Research Center in Chengdu, China
Sagent Pharmaceuticals, Inc., a leader of specialty pharmaceutical products with a specific emphasis on the injectable market, today announced the launch of its National Research Center (NRC) in Chengdu, China. Based in Chengdu's Bio-Technology Park, the NRC will focus on process and method development of technically challenging specialty injectable pharmaceuticals.

Staffed with an international team of experienced research scientists, the center will initially focus on developing both liquid and lypholization products for Sagent China Pharmaceuticals (SCP), Sagent's FDA-inspected manufacturing facility, also located in Chengdu.

"Building a first class development center in support of our manufacturing capabilities is a natural next step in our strategic evolution," said Jeffrey M. Yordon, chief executive officer and chairman of the board of Sagent. "The NRC is equipped with state-of-the-art equipment and staffed with a team of global experts in specialty injectable development. We are proud of the progress of our team in China and pleased to provide increased support for the rapid development of additional products to be manufactured at SCP."

Click here for the complete issue.


About Us | How to Contribute | How to Advertise With Us | Contact Us |

"The views expressed here does not necessarily reflect the views of Asia Pacific Biotech News or its staff."
Copyright © 2014 World Scientific Publishing Co. All rights reserved.